SCHEMBL17849223

SCHEMBL17849223

CC(C)(C)Nc1cc[nH]c(=O)c1C(=N)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
LMNA P02545 2/20 0.41
EGFR P00533 6/20 0.38
ATM Q13315 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
MAPK14 Q16539 1/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ZAP70 P43403 1/20 0.37
GSK3B P49841 1/20 0.36
ROCK1 Q13464 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17849188 0.81 EGFR (0.40) MAPTEGFRNPC1RAB9AMAPK14
SCHEMBL17849247 0.81 MAPT (0.41) MAPTEGFRNPC1MAPK1RAB9A
SCHEMBL16726659 0.79 JAK2 (0.34)
SCHEMBL16623495 0.78 GHSR (0.36) MAPTEGFRMAPK14ZAP70KDM4E
SCHEMBL17849227 0.78 TYK2 (0.42) EGFRMAPK14ZAP70HDAC3HDAC4
SCHEMBL16623576 0.77 HPGDS (0.35) EGFRMAPK14ZAP70GSK3BROCK1
SCHEMBL17849222 0.77 ALDH1A1 (0.36) MAPTLMNAEGFRNPC1RAB9A
SCHEMBL17849244 0.76 TYK2 (0.40) EGFRMAPK14ALDH1A1ZAP70KDM4E
SCHEMBL16623573 0.75 MAPT (0.34) MAPTLMNAEGFRMAPK1MAPK14
SCHEMBL17849249 0.71 EGFR (0.40) EGFRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed